What this means
This was a trial in healthy adults who each took one dose in different periods. Results were not posted, so we cannot tell how food changed how the drug moved through the body.
Plain-English summary written by an AI model from the registry listing.
- Status
- Completed
- Who can join
- Ages 18–55
- Where
- 1 site, including Illinois
The science
- Registered title
- A Phase 1 Study Assessing the Effect of Food on the Pharmacokinetics of ABBV- CLS-7262
- Trial ID
- NCT06145607 ↗
- Phase
- PHASE 1
- Study type
- interventional
- Conditions
- Healthy
- What is tested
- ABBV-CLS-7262
- Sponsor
- Calico Life Sciences LLC
- Ages
- 18 Years to 55 Years
- Dates
- First posted Nov 24, 2023 · updated Mar 8, 2024
Registry summary
This study is a randomized, three period, six sequence, single dose crossover design with ABBV-CLS-7262 in healthy adult subjects.
Sites (1)
- AbbVie Clinical Pharmacology Research Unit (ACPRU), Grayslake, Illinois, United States